Cyclosporine in the Treatment of Palmoplantar Pustulosis: A Randomized, Double-blind, Placebo-Controlled Study

Archives of Dermatology

Volumn 129, Issue 10, 1993, Pages 1273-1279

  Reitamo, Sakari ^a   Erkko, Pekka ^a   Remitz, Anita ^a   Lauerma, Antti I ^a   Montonen, Outi ^a   Harjula, Kari ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Sandoz Ltd   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMMON COLD; CREATININE BLOOD LEVEL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; NAUSEA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PUSTULOSIS PALMOPLANTARIS;

ADOLESCENT; ADULT; AGED; CYCLOSPORINE; DOUBLE-BLIND METHOD; FEMALE; HUMAN; MALE; MIDDLE AGE; PSORIASIS; SUPPORT, NON-U.S. GOV'T;

EID: 0027378081     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1993.01680310043006     Document Type: Article

References (31)

1. Rosén K. Pustulosis palmoplantaris and chronic eczematous hand dermatitis: treatment, epidermal Langerhans' cells and association with thyroid disease. Acta Derm Venereol (Stockh). 1988; 68(suppl 137): 1-52.
2. Reitamo S, Erkko P, Remitz A. Palmoplantar pustulosis. Eur J Dermatol. 1992; 2: 311-314.
3. Hradil E, Gentz CF, Matilainen T, Möller H, Sauzén L, Udén A. Skeletal involvement in pustulosis palmoplantaris with special reference to sternocostoclavicular joint. Acta Derm Venereol (Stockh). 1988; 68: 65-73.
4. Jurik AG, Ternowitz T. Frequency of skeletal disease: arthro-osteitis in patients with pustulosis palmoplantaris. J Am Acad Dermatol. 1988; 18: 666-671.
5. Rosén K, Lindstedt G, Mobacken H, Nyström E. Thyroid function in patients with pustulosis palmoplantaris. J Am Acad Dermatol. 1988; 19: 1009-1016.
6. Agner T, Sindrup JH, Hoier-Madsen M, Hegedüs L. Thyroid disease in pustulosis palmoplantaris. Br J Dermatol. 1989; 21: 487-491.
7. O'Doherty CJ, Macintyre C. Palmoplantar pustulosis and smoking. BMJ. 1985; 291: 861-864.
8. Cox NH, Ray S. Neutrophil leucocyte morphology, cigarette smoking and palmoplantar pustulosis. Int J Dermatol. 1987; 26: 445-447.
9. Ward JM, Corbett MF, Hanna MJ. A double-blind trial of clomocycline in the treatment of resistent palmoplantar pustulosis. Br J Dermatol. 1976; 95: 317-322.
10. Lassus A, Lauharanta J, Eskelinen A. The effect of etretinate compared with different regimens of PUVA in the treatment of persistent palmoplantar pustulosis. Br J Dermatol. 1985; 112: 455-459.
11. Lassus A, Geiger JM. Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial. Br J Dermatol. 1988; 119: 755-759.
12. Reitamo S, Puska P, Lassus A. Cyclosporin in the treatment of palmoplantar pustulosis. Br J Dermatol. 1989; 120: 857.
13. Meinardi MMHM, de Rie MA, Bos JD. Oral cyclosporin A is effective in clearing persistent pustulosis palmaris et plantaris. Acta Derm Venereol (Stockh). 1990; 70: 77-81.
14. Timonen P, Friend D, Abeywickrama K, Laburte C, von Graffenried B, Feutren G. Efficacy of low-dose cyclosporin A in psoriasis: results of dose-finding studies. Br J Dermatol. 1990; 122(suppl 36): 33-39.
15. Christophers E, Mrowietz U, Henneicke H-H, Färber L, Welzel D, and the participants in the German multicenter study. Cyclosporine in psoriasis: a multicenter dose-finding study in severe plaque psoriasis. J Am Acad Dermatol. 1992; 26: 86-90.
16. Hellgren L, Mobacken H. Pustulosis palmaris et plantaris: prevalence, clinical observations and prognosis. Acta Derm Venereol (Stockh). 1971; 51: 284-288.
17. Enfors W, Molin L. Pustulosis palmaris et plantaris: a follow-up study of a 10-year material. Acta Derm Venereol (Stockh). 1971; 51: 289-294.
18. Soon-Siong P, Grewal IS. Enhancement of lectin-induced cap formation in human neutrophils by cyclosporin A. Biochem Biophys Res Commun. 1988; 151: 435-440.
19. Descamps-Latscha B, Nguyen AT, Feutren G. Phagocyte oxidative metabolism in cyclosporineor placebo-treated patients with insulin-dependent (type I) diabetes mellitus of recent onset. J Autoimmunol. 1990; 3: 201-203.
20. Ormrod DJ, Cawley S, Miller TE. Cyclosporin A modulation of the acute inflammatory response: an explanation for the effect of CsA on host defences in infection. Br J Exp Pathol. 1990; 71: 69-82.
21. Kurokawa T, Nonami T, Kobyashi H, et al. Inhibition by cyclosporine of the production of superoxide radicals. N Engl J Med. 1992; 326: 840.
22. Foster CA, Yokozeki H, Rappersberger K, et al. Human epidermal T cells predominantly belong to the lineage expressing α/β T-cell receptor. J Exp Med. 1990; 171: 997-1013.
23. Bacharach-Buhles M, Altmeyer P. Pustulosis palmoplantaris: how initial ultrastructural alterations change into vesicles and pustules. Acta Derm Venereol (Stockh). 1989; 69(suppl 146): 76-80.
24. Murphy GF, Shepard RS, Harrist TJ, Bronstein BR, Bhan AK. Ultrastructural documentation of HLA-DR-antigen reactivity in normal human acrosyringium. J Invest Dermatol. 1983; 81: 181-183.
25. Reitamo S, Anttila HSI, Didierjean L, Saurat J-H. Immunohistochemical identification of interleukin 1 a and β in human eccrine sweat-gland apparatus. Br J Dermatol. 1990; 122: 315-323.
26. Anttila HSI, Reitamo S, Erkko P, Ceska M, Moser B, Baggiolini M. Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis. J Invest Dermatol. 1992; 98: 96-101.
27. Ellis CN, Fradin MS, Messana JM, et al. Cyclosporine for plaque-type psoriasis: results of a multidose, double-blind trial. N Engl J Med. 1991; 324: 277-284.
28. Mihatsch MJ, Wolff K. Consensus conference on cyclosporin A for psoriasis, February 1992. Br J Dermatol. 1992; 126: 621-623.
29. Reitamo S, Remitz A, Erkko P, Kurki P. Cyclosporin treatment of psoriasis: Recommendations based on the use of cyclosporin A in over 100 patients in Helsinki. Clin Nephrol. In press.
30. Feutren G, Mihatsch J. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med. 1992; 326: 1654-1660.
31. Lindholm A, Zachariae H, Reitamo S, et al. Is cyclosporine blood concentration monitoring necessary in patients treated for severe chronic plaque form psoriasis? Transplant Proc. 1990; 22: 1293-1295.